Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.
暂无分享,去创建一个
J. Girault | P. Rouanet | T. Maudelonde | A. Kramar | S. Gourgou | J. Grenier | G. Linares‐Cruz | S. Poujol | J. Simony‐Lafontaine | F. Dravet | E. Le Nestour